Characterization and localization of a putative morphine-modulating peptide, FLFQPQRFamide, in the rat spinal cord: biochemical and immunocytochemical studies.
The bovine octapeptide Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 (FLFQPQRFamide), originally detected by antisera raised against the invertebrate peptide, Phe-Met-Arg-Phe-NH2, is a neuropeptide which antagonizes the actions of endogenous and exogenous opiates. Using a sensitive radioreceptor assay, we show that rat spinal cord extracts were able to inhibit binding of FLFQPQRFamide, suggesting that a biologically active FLFQPQRFamide-like material exists in the rat spinal cord. We also raised antibodies against the peptide and used them, together with radioimmunological and immunohistochemical methods, to characterize this material further and analyse its cellular and subcellular localization in this area of the central nervous system. Radioimmunoassay showed that extracts from cervical and thoracolumbar levels contained measurable amounts of FLFQPQRFamide-immunoreactive material (about 3 ng/g tissue), present essentially in the dorsal horn. Analytical reverse-phase chromatography revealed that this material existed in several molecular forms. One of these fractions (about 20% of the total immunoreactivity) had the elution characteristics of synthetic FLFQPQRFamide. Light microscopic immunohistochemistry showed FLFQPQRFamide immunoreactivity at all spinal levels, localized mainly in a dense plexus of fibers in the superficial layers of the dorsal horn. Immunoreactive profiles were also seen in the lateral funiculi and around the central canal at all levels and in the intermediolateral columns; some rare immunoreactive fibers were also noted in the ventral horn at cervical and thoracic levels. FLFQPQRFamide-positive cell bodies were never detected in any of our sections. Electron microscopy of ultrathin sections of the dorsal horn and central gray treated with our antisera and a post-embedding immunogold procedure revealed that the immunoreactivity, at least within these areas, was restricted to dense-cored vesicles (90-120 nm in diameter) in axonal and terminal profiles. As seen by radioimmunoassay and immunohistochemistry, unilateral rhizotomy of all dorsal roots between segments C4 and T2 did not change the levels of FLFQPQRFamide immunoreactivity in the ipsilateral C6-C8 segments. Taken together with our recent data showing the existence of specific FLFQPQRFamide receptors at the spinal cord level, our present observations suggest that the dorsal horn of the rat spinal cord may be a site where vertebrate Phe-Met-Arg-Phe-like peptides, and in particular, FLFQPQRFamide, may exert opiate modulating activities.
Allard
M
M
Unité de Neurobiologie des Comportements, INSERM U.176, Université de Bordeaux II, France.
Theodosis
D T
DT
Rousselot
P
P
Lombard
M C
MC
Simonnet
G
G
D000818:Animals; D007150:Immunohistochemistry; D008297:Male; D009020:Morphine / Q000378:metabolism*; D009479:Neuropeptides / Q000494:pharmacology; D009842:Oligopeptides / Q000494:pharmacology*; D011863:Radioimmunoassay; D051381:Rats; D013116:Spinal Cord / Q000378:metabolism*; D014018:Tissue Distribution; D014020:Tissue Extracts / Q000378:metabolism
D009479:Neuropeptides; D009842:Oligopeptides; D014020:Tissue Extracts; D009020:Morphine; C053651:phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide